Decannulation with a medical device
DeviceWound Closure with a medical device
NCT Number: NCT07019662
Background:
Patients with severe heart and lung failure may be treated with VA-ECMO (veno-arterial extracorporeal membrane oxygenation), a life-support machine that temporarily takes over the function of the heart and lungs. To connect the patient to ECMO, large tubes (cannulas) are inserted into major blood vessels in the groin area.
When the patient no longer needs ECMO, these cannulas must be removed - a process known as decannulation. Closing the artery after removing the cannula is a critical step and can be associated with complications such as bleeding, vessel injury, or blood clots.
Currently, there are different methods to close the artery:
* Surgical closure: open surgery to directly suture the artery * Manual compression: pressing on the artery to stop bleeding * Vascular closure devices (VCDs): special tools that close the artery through the skin
There is no clear standard yet on which method is safest and most effective for ECMO patients.
Purpose of the Study:
The study aims to determine whether using a vascular closure device is as safe and effective as the current standard methods for femoral artery closure after VA-ECMO.
Study Design:
This is a randomized controlled trial. Patients who are scheduled for decannulation after VA-ECMO support will be randomly assigned to one of two groups:
* Intervention Group: Patients receive a vascular closure device to seal the artery (Abbott Perclose™ ProStyle™ Suture-Mediated Closure System). * Control Group: Patients receive standard care, which may be either:
* Manual compression, or * Surgical closure, depending on the treating physician's judgment and the patient's condition.
This allows for a real-world comparison of the Closure Device method to current clinical practice.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Universitäres Herz- und Gefäßzentrum Frankfurt ZIM - Med. Clinic 3 - Cardiology and Angiology, Frankfurt, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wound Closure with a medical device
Wound closure using surgical removal or manual compression
Time frame: within 48 hours post ECMO removal
Time frame: Prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: Prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: Prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: Prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Time frame: At 48 hours post-ECMO and prior to hospital discharge, but no longer than 30 days after ECMO decannulation, whichever occurs first
Contact information is provided by the study sponsor or research team.
IHF GmbH - Institut für Herzinfarktforschung
Other
Acronym: CLOSE-ECMO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07141524
Pathologic Processes, Pathological Conditions, Signs and Symptoms
Boston, Massachusetts, United States
View Trial DetailsNCT05290805
Cardiopulmonary Arrest, Cardiovascular Diseases
Vienna, State of Vienna, Austria
View Trial Details